目前,尽管抗病毒疗法取得很大进展,丙型肝炎病毒(HCV)感染仍为一个世界关注的主要健康问题。人们一直在致力于寻找具新的作用机制,如作用于病毒特异性酶的抗HCV新药,因为α-葡糖苷酶Ⅰ参与病毒表面糖蛋白的生物合成,而这种糖蛋白是病毒与宿主间相互作用所必需的,因此抑制α-葡 At present, hepatitis C virus (HCV) infection remains a major health concern of the world despite significant advances in antiretroviral therapy. People are always looking for new mechanisms of action, such as anti-HCV drugs acting on virus-specific enzymes, because a-glucosidase I is involved in the biosynthesis of viral surface glycoproteins, which are virus-to-host Necessary for interaction, thus inhibiting alpha-glucagon